Case details

Court: ded
Docket #: 1:14-cv-00157
Case Name: Novartis Pharmaceuticals Corporation et al v. Dr Reddy's Laboratories Ltd et al
PACER case #: 54170
Date filed: 2014-02-05
Date terminated: 2015-06-22
Assigned to: Judge Leonard P. Stark
Case Cause: 35:271 Patent Infringement
Nature of Suit: 830 Patent
Jury Demand: None
Jurisdiction: Federal Question

Parties

Represented Party Attorney & Contact Info
Novartis Pharmaceuticals Corporation
Plaintiff
Michael P. Kelly
McCarter & English, LLP Renaissance Centre 405 N. King Street, 8th Floor Wilmington, DE 19801 (302) 984-6301 Fax: (302) 984-6399 Email: mkelly@mccarter.com
LEAD ATTORNEY ATTORNEY TO BE NOTICED

Daniel M. Silver
McCarter & English, LLP Renaissance Centre 405 N. King Street, 8th Floor Wilmington, DE 19801 (302) 984-6300 Fax: (302) 691-1260 Email: dsilver@mccarter.com
ATTORNEY TO BE NOTICED

David K. Barr
Email: david.barr@kayescholer.com
PRO HAC VICE ATTORNEY TO BE NOTICED

Novartis AG
Plaintiff
Michael P. Kelly
(See above for address)
LEAD ATTORNEY ATTORNEY TO BE NOTICED

Daniel M. Silver
(See above for address)
ATTORNEY TO BE NOTICED

Dr Reddy's Laboratories Ltd
Defendant
Neal C. Belgam
Smith, Katzenstein, & Jenkins LLP The Corporate Plaza 800 Delaware Ave. P.O. Box 410 Wilmington, DE 19899 (302) 652-8400 Email: nbelgam@skjlaw.com
LEAD ATTORNEY ATTORNEY TO BE NOTICED

Ajay Kayal
Email: akayal@buddlarner.com
PRO HAC VICE ATTORNEY TO BE NOTICED

Alan H. Pollack
Email: apollack@buddlarner.com
PRO HAC VICE ATTORNEY TO BE NOTICED

Constance S. Huttner
Email: chuttner@buddlarner.com
PRO HAC VICE ATTORNEY TO BE NOTICED

Dr. Reddy's Laboratories Inc.
Defendant
Neal C. Belgam
(See above for address)
LEAD ATTORNEY ATTORNEY TO BE NOTICED

Documents

Date Filed Document # Attachment # Short Description Long Description Upload date SHA1 hash
2014-02-05 1 0 COMPLAINT FOR PATENT INFRINGEMENT filed against Dr Reddy's Laboratories Ltd, Dr. Reddy's Laboratories Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1455789.) - filed by Novartis Pharmaceuticals Corporation, Novartis AG. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(els) (Entered: 02/06/2014)
2014-02-05 2 0 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (els) (Entered: 02/06/2014)
2014-02-05 3 0 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/24/13. Date of Expiration of Patent: 5/23/19.Thirty Month Stay Deadline: 6/24/2016. (els) (Entered: 02/06/2014)
2014-02-05 4 0 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,894,051;. (els) (Entered: 02/06/2014)
2014-02-05 5 0 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation. (els) (Entered: 02/06/2014)
2014-02-05 6 0 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Novartis AG. (els) (Entered: 02/06/2014)
2014-02-20 7 0 DECLARATION of Mailing Regarding Service on Dr. Reddy's Laboratories, Ltd. made on February 6th, 2014 by Novartis AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibit (A-B))(Silver, Daniel) (Entered: 02/20/2014)
2014-02-20 8 0 DECLARATION of Mailing Regarding Service on Dr. Reddy's Laboratories, Inc. made on February 6th, 2014 by Novartis AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibit (A-B))(Silver, Daniel) (Entered: 02/20/2014)
2014-02-26 9 0 ANSWER to 1 Complaint, by Dr Reddy's Laboratories Ltd, Dr. Reddy's Laboratories Inc..(Belgam, Neal) (Entered: 02/26/2014)
2014-02-26 10 0 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Dr. Reddy's Laboratories, Ltd. for Dr Reddy's Laboratories Ltd, Dr. Reddy's Laboratories Inc. filed by Dr Reddy's Laboratories Ltd, Dr. Reddy's Laboratories Inc.. (Belgam, Neal) (Entered: 02/26/2014)
2014-03-17 11 0 NOTICE of Notice of Withdrawal of Fourth Defense of Lack of Personal Service on Dr. Reddy's Laboratories, Ltd. by Dr Reddy's Laboratories Ltd, Dr. Reddy's Laboratories Inc. re 9 Answer to Complaint (Belgam, Neal) (Entered: 03/17/2014)
2014-03-19 12 0 MOTION for Pro Hac Vice Appearance of Attorney Alan Pollack - filed by Dr Reddy's Laboratories Ltd, Dr. Reddy's Laboratories Inc.. (Attachments: # 1 Certification by Counsel)(Belgam, Neal) (Entered: 03/19/2014)
2014-03-19 13 0 MOTION for Pro Hac Vice Appearance of Attorney Ajay Kayal - filed by Dr Reddy's Laboratories Ltd, Dr. Reddy's Laboratories Inc.. (Attachments: # 1 Certification by Counsel)(Belgam, Neal) (Entered: 03/19/2014)
2014-03-20 14 0 MOTION for Pro Hac Vice Appearance of Attorney David K. Barr - filed by Novartis AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Certification by Counsel)(Silver, Daniel) (Entered: 03/20/2014)
2014-04-21 15 0 MOTION for Pro Hac Vice Appearance of Attorney Constance S. Huttner - filed by Dr Reddy's Laboratories Ltd, Dr. Reddy's Laboratories Inc.. (Attachments: # 1 Certification by Counsel)(Belgam, Neal) (Entered: 04/21/2014)
2014-05-23 16 0 ORAL ORDER: IT IS HEREBY ORDERED that the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposal, including a proposal for the length and timing of trial, to the Court no later than June 9, 2014. The parties are to review the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Stark, Forms). ORDERED by Judge Leonard P. Stark on 5/23/14. (ntl) (Entered: 05/23/2014)
2014-06-05 17 0 STIPULATION TO EXTEND TIME for The Parties to Submit a Proposed Scheduling Order to Friday, August 8, 2014 (from Monday, June 9, 2014) - filed by Novartis AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 06/05/2014)
2014-07-28 18 0 Joint STIPULATION TO EXTEND TIME to submit a proposed case scheduling order to September 8, 2014 - filed by Dr Reddy's Laboratories Ltd, Dr. Reddy's Laboratories Inc.. (Belgam, Neal) (Entered: 07/28/2014)
2014-09-03 19 0 STIPULATION TO EXTEND TIME The Parties to Submit a Proposed Schedule to Friday, November 7, 2014 (from September 8, 2014) - filed by Novartis AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 09/03/2014)
2014-11-03 20 0 Joint STIPULATION and Proposed Order To Extend Time To Submit Proposed Case Schedule To January 7, 2015 by Novartis AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 11/03/2014)
2015-01-06 21 0 STIPULATION TO EXTEND TIME for the Parties to Submit a Proposed Schedule to Monday, February 9, 2015 (from Wednesday, January 7, 2015) - filed by Novartis AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 01/06/2015)
2015-02-06 22 0 STIPULATION TO EXTEND TIME for the Parties to Submit a Proposed Schedule to Monday, March 9, 2015 (from February 9, 2015) - filed by Novartis AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 02/06/2015)
2015-02-26 23 0 STIPULATION TO EXTEND TIME for the Parties to Submit a Proposed Scheduling Order to Friday, May 8, 2015 (from Monday, March 9, 2015 in C.A. No. 14-157 and Monday, March 2, 2015 in C.A. Nos. 14-387, 14-1076 and 14-1283) - filed by Novartis AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 02/26/2015)
2015-05-05 24 0 STIPULATION TO EXTEND TIME regarding the Deadline for the Parties to Submit a Proposed Scheduling Order to Wednesday, July 8, 2015 (from Friday, May 8, 2015) - filed by Novartis AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 05/05/2015)
2015-06-18 25 0 STIPULATION of Dismissal and [Proposed] Order Without Prejudice Under Federal Rule of Civil Procedure 41(a)(2) by Novartis AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 06/18/2015)
2015-07-02 26 0 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,894,051. (ntl) (Entered: 07/02/2015)